Biosimilars
-
-
Aaron S. Kesselheim Ameet Sarpatwari Empirical Health Law Policy Insurance Medicare/Medicaid Pharmaceuticals PORTAL Round-UpMonthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Aaron S. Kesselheim Abortion Ameet Sarpatwari Beatrice Brown Generic Drugs Health Law Policy Intellectual Property Medicare/Medicaid Pharmaceuticals PORTAL Round-UpMonthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
The Risk of Pervasive Trade Secret Practices Within the Life Sciences
Read more: The Risk of Pervasive Trade Secret Practices Within the Life Sciences -
Aaron S. Kesselheim Ameet Sarpatwari Beatrice Brown Clinical Research Empirical FDA Health Law Policy Medical devices Opioid Crisis Pharmaceuticals PORTAL Round-UpMonthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
The Ongoing Step Therapy Debate
Read more: The Ongoing Step Therapy Debate -
Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported?
Read more: Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported? -
When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims -
Year in Review: Biosimilars
Read more: Year in Review: Biosimilars -
Aaron S. Kesselheim Ameet Sarpatwari Beatrice Brown FDA Health Law Policy Pharmaceuticals PORTAL Round-Up Publications Scientific Evidence
Monthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy